GlaxoSmithKline to reduce AIDS drugs price

Britain's GlaxoSmithKline PLC, the world's largest producer of AIDS drugs, announced it would reduce the price of its popular AIDS medication. Combivir, a leading AIDS combination therapy, will drop from $1.70 to 90 cents a day. Epivir, also called 3TC, will drop from 64 cents to 35 cents a day, and Retrovir, known as AZT, will drop from $1.20 to 75 cents a day in sixty-three developing countries, including sub-Saharan Africa. The price reductions were made possible by improvements in manufacturing, according to Glaxo. The world's biggest maker of HIV drugs has significant operations in the Philadelphia area. Click here to read more on the HIV-Aids feature on our site. Source: http://www.news24.com/News24/On_this_day/On_this_day/0,,2-1602-1492_1515387,00.html